Defining "Continuous Deep Sedation" Using Treatment Protocol: A Proposal Article

Overview

Journal Palliat Med Rep

Specialty Critical Care

Date 2022 Oct 20

PMID 36262550

Authors

Tatsuya Morita

Kengo Imai

Masanori Mori

Naosuke Yokomichi

Satoru Tsuneto

Affiliations

Soon will be listed here.

Abstract

Continuous deep sedation (CDS) is regarded as a far-reaching form of sedative use for symptom control, but there are no established uniform definitions. To propose types of sedative use related to CDS using treatment protocols with three parameters: documented treatment goals, rapidity of dose titration, and planned duration of treatment. Opinion article. We propose four types of sedative use potentially related to CDS: (1) proportional sedation (treatment goal is symptom relief with regular monitoring to maximize patient communication, not a decrease in consciousness; with gradual use of sedatives; there is a chance to cease sedatives), (2) rapid proportional sedation (treatment goal is symptom relief with a rapid loading phase, followed by regular monitoring to maximize patient communication; there is a chance to cease sedatives), (3) deep sedation with a chance of cessation (deep sedation intended initially, followed by regular assessments of appropriateness of treatment goal; there is a chance to cease sedatives), and (4) continuous deep sedation until death (deep sedation indicated from initiation and maintained until death). This article proposes an idea that the use of treatment protocols that visualize treatment goals, rapidity of dose titration, and planned duration of treatment may help understand the existing variations in sedative use over the world. The use of treatment protocols in the same way when defining a medical treatment in other specialty fields might clear up the current confusion about the use of sedatives.

Citing Articles

Response to Morita et al., Re: " (DOI: 10.1089/pmr.2021.0058).

Twycross R Palliat Med Rep. 2022; 3(1):105-106.

PMID: 35919384 PMC: 9279122. DOI: 10.1089/pmr.2022.0020.

Response to Morita et al., Re: (DOI: 10.1089/pmr.2021.0058).

Broeckaert B Palliat Med Rep. 2022; 3(1):96-97.

PMID: 35919383 PMC: 9279116. DOI: 10.1089/pmr.2022.0018.

References

Twycross R . Reflections on palliative sedation. Palliat Care. 2019; 12:1178224218823511. PMC: 6350160. DOI: 10.1177/1178224218823511. View

Serey A, Tricou C, Phan-Hoang N, Legenne M, Perceau-Chambard E, Filbet M . Deep continuous patient-requested sedation until death: a multicentric study. BMJ Support Palliat Care. 2019; 13(1):70-76. DOI: 10.1136/bmjspcare-2018-001712. View

Bretonniere S, Fournier V . Continuous Deep Sedation Until Death: First National Survey in France after the 2016 Law Promulgating It. J Pain Symptom Manage. 2021; 62(4):e13-e19. DOI: 10.1016/j.jpainsymman.2021.03.009. View

Chambaere K, Bilsen J, Cohen J, Rietjens J, Onwuteaka-Philipsen B, Mortier F . Continuous deep sedation until death in Belgium: a nationwide survey. Arch Intern Med. 2010; 170(5):490-3. DOI: 10.1001/archinternmed.2009.542. View

Monreal-Carrillo E, Allende-Perez S, Hui D, Garcia-Salamanca M, Bruera E, Verastegui E . Bispectral Index monitoring in cancer patients undergoing palliative sedation: a preliminary report. Support Care Cancer. 2017; 25(10):3143-3149. DOI: 10.1007/s00520-017-3722-8. View

Porzio G, Aielli F, Verna L, Micolucci G, Aloisi P, Ficorella C . Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study. Support Care Cancer. 2009; 18(1):77-81. DOI: 10.1007/s00520-009-0632-4. View

Putman M, Yoon J, Rasinski K, Curlin F . Intentional sedation to unconsciousness at the end of life: findings from a national physician survey. J Pain Symptom Manage. 2012; 46(3):326-34. DOI: 10.1016/j.jpainsymman.2012.09.007. View

Seymour J, Rietjens J, Bruinsma S, Deliens L, Sterckx S, Mortier F . Using continuous sedation until death for cancer patients: a qualitative interview study of physicians' and nurses' practice in three European countries. Palliat Med. 2014; 29(1):48-59. PMC: 4266692. DOI: 10.1177/0269216314543319. View

Kirk T, Mahon M . National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage. 2010; 39(5):914-23. DOI: 10.1016/j.jpainsymman.2010.01.009. View

10.

Imai K, Morita T, Yokomichi N, Kawaguchi T, Kohara H, Yamaguchi T . Efficacy of Proportional Sedation and Deep Sedation Defined by Sedation Protocols: A Multicenter, Prospective, Observational Comparative Study. J Pain Symptom Manage. 2021; 62(6):1165-1174. DOI: 10.1016/j.jpainsymman.2021.06.005. View

11.

Cherny N . ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation. Ann Oncol. 2014; 25 Suppl 3:iii143-52. DOI: 10.1093/annonc/mdu238. View

12.

Tomczyk M, Dieudonne-Rahm N, Jox R . A qualitative study on continuous deep sedation until death as an alternative to assisted suicide in Switzerland. BMC Palliat Care. 2021; 20(1):67. PMC: 8122537. DOI: 10.1186/s12904-021-00761-y. View

13.

Schofield G, Baker I, Bullock R, Clare H, Clark P, Willis D . Palliative opioid use, palliative sedation and euthanasia: reaffirming the distinction. J Med Ethics. 2019; 46(1):48-50. DOI: 10.1136/medethics-2018-105256. View

14.

Abarshi E, Rietjens J, Robijn L, Caraceni A, Payne S, Deliens L . International variations in clinical practice guidelines for palliative sedation: a systematic review. BMJ Support Palliat Care. 2017; 7(3):223-229. DOI: 10.1136/bmjspcare-2016-001159. View

15.

Imai K, Morita T, Yokomichi N, Mori M, Naito A, Tsukuura H . Efficacy of two types of palliative sedation therapy defined using intervention protocols: proportional vs. deep sedation. Support Care Cancer. 2017; 26(6):1763-1771. DOI: 10.1007/s00520-017-4011-2. View

16.

Ghafoor V, Silus L . Developing policy, standard orders, and quality-assurance monitoring for palliative sedation therapy. Am J Health Syst Pharm. 2011; 68(6):523-7. DOI: 10.2146/ajhp090177. View

17.

Sulmasy D . The last low whispers of our dead: when is it ethically justifiable to render a patient unconscious until death?. Theor Med Bioeth. 2018; 39(3):233-263. DOI: 10.1007/s11017-018-9459-7. View

18.

Sykes N, Thorns A . The use of opioids and sedatives at the end of life. Lancet Oncol. 2003; 4(5):312-8. DOI: 10.1016/s1470-2045(03)01079-9. View

19.

Orsi L, Gristina G . Palliative sedation: the position statement of the Italian National Committee for Bioethics. Minerva Anestesiol. 2016; 83(5):524-528. DOI: 10.23736/S0375-9393.16.11736-5. View

20.

Ziegler S, Schmid M, Bopp M, Bosshard G, Puhan M . Continuous Deep Sedation Until Death-a Swiss Death Certificate Study. J Gen Intern Med. 2018; 33(7):1052-1059. PMC: 6025678. DOI: 10.1007/s11606-018-4401-2. View